Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on DANIELI & CO. We currently have 5 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
DANIELI & CO
DANIELI & CO
FY15/16 results : disappointing
28 Sep 16
Danieli released FY15/16 results (closing 30 June). Revenues reached €2,508.4m (-9%), EBITDA €211.4m (-17%), EBIT €90.2m (-40%) and the net result €88.3m (-45%). The order book at the end of June reached €2,814m (-5%). The group’s net cash at the end of fiscal 2015/16 stood at €908m (-5%). A dividend of €0.10 per share (€0.1207 for savings shares) will be proposed at the group’s AGM on 28 October.
Q3 16: the same trend as in H1
12 May 16
Danieli released 9 months figures. Revenues reached €1,691.3m (-15%), EBITDA €154m (-11%), EBIT €78.3m (-22%) and net income €54m (-54%). Net cash at the end of March 2016 amounted to €823.5m (vs €841.8m at the end of H1 and €956m a year before). The group’s order book stood at €2,975m (vs €3,026m in December and €3,155m at the end of the last fiscal year.
H1 15/16: in line
26 Feb 16
Danieli’s H1 15/16 results were released. Revenues reached €1,161.1m (-14%), EBITDA €108.4m (-14%), EBIT €55.4m (-30%) and net profit €45m (-32%). Net cash at the end of H1 was €841.8m (vs €956m at year end 14/15 and €881m in Q1). The group’s order book stood at €3,026m (vs €3,155m in June 2015 and €3,094m at the end of Q1). The group confirms the FY16 results should be in line with the forecasts made at the beginning of the year (i.e. revenues of €2,700-2,850m and an EBITDA of €240-260m).
Q1 15/16: signs of weakness
13 Nov 15
Danieli released Q1 15/16 results (as at 30 September 2015). Sales reached €556m (-15% yoy), EBITDA €51.6m (-22% yoy), EBIT €28.1m (-35% yoy) and the net result €22.5m (-58% yoy). Net cash at the end of Q1 15/16 was €880.5m (8% down from €956m at year end 2014/15). The group’s order book stood at €3,094m (-2% qoq, of which -9% in Steel Making to €154m).
FY14/15 in line. Dividend cut and no outlook (yet) released for 2015/16
25 Sep 15
Danieli released its FY14/15 results. Revenues reached €2,765.9m (-6%), EBITDA €250.5m (-19%), EBIT €150.2m (-29%) and the net result (group share) €161.8m (+5%). Net cash at the end of the year reached €956m (vs €844.3m a year before) and the order book €3,155m (+2% yoy and +15% sequentially). The company will cut its dividend to €0.10 (vs €0.30 last year), reducing its pay-out from 13-15% historically to a mere 5%.
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
16 Jan 17
We take a look at the rankings of the various countries in Africa that have a significant exposure to mining. We take the Transparency International corruption rankings as our starting point and modify these for exceptional geology and for current UK government travel warnings. Ghana, Botswana and Namibia come out as our top three, with Eritrea, Kenya and Zimbabwe at the bottom of our rankings.
19 Jan 17
Aggregated Micro Power* (AMPH): Funding for first peaking power plant project (CORP) | The Mission Marketing Group* (TMMG): Positive trading update (CORP) | Cello (CLL): Increasingly backed by, and leveraging, technology (BUY) | 4imprint (FOUR): Growth backed by strong cash flow continues (BUY) | Allergy Therapeutics (AGY): Positive trading update and market share gains drive upgrades (BUY) | Shanta Gold (SHG): Q4 operating results (BUY) | Sound Energy (SOU): Tendrara extended well test result (BUY) | Revolution Bars (RBG): Price target increase (BUY)
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - St Ives - Downgrade
19 Jan 17
Marketing activation has been impacted by further decline in grocery retail impacting profit by c£5m. Strategic The Company is also taking this opportunity to revise its guidance for Strategic Marketing as its recovery pace is not running at the planned target rate. PBT falls from N1Se £31.9m to £25m. The Company expects dividend to be held based upon lowered guidance and the implied cash flow performance. There do not appear to be any covenant issues. Forecasts and TP under review and downgrade to Hold. We expect the shares to test the 100p level.
N+1 Singer - Morning Song 19-01-2017
19 Jan 17
Actual Experience (ACT LN) 2017 – a milestone year for revenue | Bagir Group (BAGR LN) Independent NED appointment to strengthen Board composition | Bioquell (BQE LN) Reassuring pre-close statement | Carador Income Fund (CIFU LN) Q4 dividend increased to 2.75c, 0.5c higher than forecast | FreeAgent (FREE LN) Contract with Royal Bank of Scotland | Halfords Group (HFD LN) Excellent Q3 update, special divi and confidence in FX mitigations | N Brown Group (BWNG LN) Robust peak trading with reversal of drag from older titles | NCC Group (NCC LN) Interims confirm underlying business sound | St Ives (SIV LN) Downgrade | Summit Therapeutics (SUMM LN) Dr David Roblin appointed Chief Operating Officer and R&D President | Wilmington Group (WIL LN) Acquisition – Further scaling of Healthcare